March 2026 in “Journal of Epidemiology & Community Health” In this study, researchers analyzed English primary care data and found that long-COVID symptoms such as fatigue, cognitive, and mobility impairments persisted at 6–12 months after infection, though these effects were generally less pronounced following the later pandemic wave.
March 2026 in “Preprints.org” This study investigated the secretome of adipose mesenchymal stem cells and fibroblasts used in skin care products, finding 16 therapeutic pathways involving numerous signaling mechanisms, which may offer skin benefits through anti-inflammatory and regenerative effects.
March 2026 in “Wound Repair and Regeneration” In this study, researchers used a mouse model to demonstrate that expression of MARCKSL1 in dendritic cells plays a crucial role in modulating fibrotic responses and scar formation during wound healing, suggesting that targeting this expression could offer new therapeutic strategies for scar prevention.
January 2026 in “Clinical & Translational Oncology” This expert consensus statement highlights that while targeted cancer therapies significantly improve patient survival, they often result in various skin toxicities, underscoring the need for early diagnosis, management, and multidisciplinary care to maintain patients' quality of life and ensure treatment continuity.
January 2026 in “American Journal of Medical Genetics Part A” The researchers reported two brothers with a new variant of X-linked trichothiodystrophy associated with an RNF113A gene mutation, highlighting features such as intellectual disability and growth failure, but without previously reported endocrinological or genital abnormalities, underlining the importance of genetic counseling for such variants.
Dynaplast tape reduces swelling after hair transplants effectively.
December 2025 in “FEBS Open Bio” In this study, fibroblasts from long-term skin biopsy cultures retained their ability to reprogram into induced pluripotent stem cells after 16 months, despite undergoing transcriptional changes and decreased proliferation rates over successive generations.
November 2025 in “Journal of the European Academy of Dermatology and Venereology” In this study, single-cell RNA sequencing of hair follicle populations from hidradenitis suppurativa patients identified three endotypes, suggesting distinct epithelial-immune interactions that may guide stratified therapeutic approaches.
November 2025 in “Cermin Dunia Kedokteran” In this case report, a 16-year-old Asian girl with deep vein thrombosis and autoimmune hemolytic anemia was suspected of having systemic lupus erythematosus, highlighting the importance of early recognition of unusual SLE manifestations.
November 2025 in “The Laryngoscope” This article reviews the use of sodium fluoride in otosclerosis management, finding limited evidence of its efficacy in preventing hearing deterioration and highlighting potential toxicity concerns.
September 2025 in “Journal of Cutaneous and Aesthetic Surgery” This case report demonstrated that long-hair follicular unit extraction may effectively reconstruct the mustache area following surgical scarring, with high patient satisfaction and no complications observed.
August 2025 in “International Journal of Dermatology” This study reports that although saw palmetto extract is marketed as a natural alternative for hair loss and prostate health, its unregulated status may pose safety and efficacy risks to consumers.
July 2025 in “Journal of Investigative Dermatology”
July 2025 in “JAAD Case Reports” A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.
June 2025 in “Cell Metabolism” This study found that dietary serine levels influence hair follicle stem cells' ability to balance hair regeneration and wound repair, offering insights for potential interventions to accelerate wound healing.
March 2025 in “Expert Opinion on Drug Discovery” This article discusses the pursuit of more effective treatments for androgenetic alopecia due to its widespread psychological and social impact, but reports no new clinical findings.
January 2025 in “Nanoscale” This study reports that a new boron/nitrogen-doped carbon nano-onion-based delivery system for doxorubicin enhanced its uptake and anticancer effects in specific cancer cell types, while reducing cardiotoxicity in human heart cells.
January 2025 in “Annals of Thoracic and Cardiovascular Surgery” This case report describes a 55-year-old woman with alopecia areata whose condition improved rapidly and did not recur after the surgical resection of a thymoma, suggesting a potential immunological link between alopecia areata and thymoma that warrants further investigation.
December 2024 in “Journal of Cutaneous and Aesthetic Surgery” This review highlights recent advancements in FUE hair transplantation techniques and technologies, noting significant improvements in reducing follicle damage and increasing procedure speed, while emphasizing the need for surgeons to choose suitable devices for each patient's specific needs.
December 2024 in “Frontiers in Neurology” In this pilot randomized clinical trial, TRT combined with finasteride increased lean mass, muscle size, and bone mineral density without prostate enlargement in men with spinal cord injury, suggesting potential benefits for body composition and musculoskeletal health.
August 2024 in “Current Protocols” In this study, researchers described protocols using C3H/HeJ mice to reliably induce alopecia areata through full-thickness skin grafts or adoptive transfer of cultured lymphoid cells, offering valuable models for studying the disease and testing new drug therapies.
June 2024 in “British Journal of Dermatology” This case report highlights the diagnosis of folliculotropic mycosis fungoides in a 15-year-old boy with atypical skin and hair follicle changes, a rare occurrence in pediatric patients.
June 2024 in “British Journal of Dermatology” This study found that there is substantial variability in laboratory testing practices among dermatologists specializing in alopecia areata across the globe, indicating the need for renewed discussions around guidelines for such testing.
May 2024 in “Scientific reports” This study explored the role of Twist2 in fetal wound healing in embryonic mice, observing that its expression was vital for scarless regeneration and normal hair follicle formation; Twist2 knockdown led to visible scars and defective follicle formation.
This study observed that stimulating the cholinergic system via muscarinic receptors in dermal papilla cells and other hair-related tissues promoted hair growth, with mechanisms involving the activation of Wnt/β-catenin signalling pathways in cell cultures and increased hair shaft elongation in mouse vibrissae treated with bethanechol.
April 2024 in “International Journal of Women’s Dermatology” This study suggests that lichen planopilaris should be considered as a potential diagnosis in African American women with scarring alopecia, often displaying an "arrowhead" distribution pattern, which may guide treatment strategies.
March 2024 in “Authorea (Authorea)” This retrospective case series reports on the use of STRAVIX PL, a shelf-stable human umbilical tissue allograft, in managing recurrent pilonidal cyst wounds, suggesting potential benefits in reducing recurrence and providing durable wound coverage compared to traditional methods.
March 2024 in “Research Square (Research Square)” In this study, researchers found that the protein Twist2 plays a crucial role in scarless wound healing in early embryonic mouse skins, with its knockdown leading to visible scarring and defective hair follicle formation, suggesting potential therapeutic targets for reducing scars and promoting regeneration.
This study found that the transcription factor Meis2 regulates the maturation and innervation of sensory neurons in mice, affecting their response to light touch.
January 2024 in “Anaesthesia reports” Using a gel head pad during surgery can cause hair loss in children.